Patent · US Active

Sclerostin-binding antibodies

US7872106B2 · kind B2 · utility

47Cited by
44References
25Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 24, 2008
Grant dateJan 18, 2011
Priority date—
Expiry dateNov 24, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods relating to epitopes of sclerostin protein, and sclerostin binding agents, such as antibodies capable of binding to sclerostin, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.